Delta Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.33M | Buy |
17,205
+240
| +1% | +$51.6K | 1.99% | 7 |
|
|
2026
Q1 | $3.69M | Sell |
16,965
-130
| -0.8% | -$28.8K | 2.03% | 11 |
|
|
2025
Q4 | $3.91M | Sell |
17,095
-1,870
| -10% | -$426K | 2.19% | 9 |
|
|
2025
Q3 | $4.39M | Sell |
18,965
-55
| -0.3% | -$11.2K | 2.27% | 10 |
|
|
2025
Q2 | $3.53M | Buy |
19,020
+9,680
| +104% | +$1.8M | 1.97% | 19 |
|
|
2025
Q1 | $1.96M | Sell |
9,340
-490
| -5% | -$95.3K | 1.14% | 38 |
|
|
2024
Q4 | $1.75M | Sell |
9,830
-40
| -0.4% | -$7.35K | 1% | 40 |
|
|
2024
Q3 | $1.95M | Hold |
9,870
| – | – | 1.12% | 41 |
|
|
2024
Q2 | $1.69M | Sell |
9,870
-10
| -0.1% | -$1.66K | 1.02% | 41 |
|
|
2024
Q1 | $1.8M | Hold |
9,880
| – | – | 1.19% | 41 |
|
|
2023
Q4 | $1.53M | Sell |
9,880
-10
| -0.1% | -$1.46K | 1.07% | 43 |
|
|
2023
Q3 | $1.47M | Sell |
9,890
-540
| -5% | -$79.3K | 1.1% | 42 |
|
|
2023
Q2 | $1.41M | Sell |
10,430
-220
| -2% | -$32.3K | 0.97% | 42 |
|
|
2023
Q1 | $1.7M | Sell |
10,650
-60
| -0.6% | -$9.17K | 1.19% | 36 |
|
|
2022
Q4 | $1.73M | Buy |
10,710
+20
| +0.2% | +$3.07K | 1.26% | 36 |
|
|
2022
Q3 | $1.44M | Hold |
10,690
| – | – | 1.17% | 39 |
|
|
2022
Q2 | $1.64M | Buy |
10,690
+40
| +0.4% | +$6.11K | 1.23% | 41 |
|
|
2022
Q1 | $1.73M | Sell |
10,650
-1,860
| -15% | -$270K | 1.15% | 42 |
|
|
2021
Q4 | $1.69M | Buy |
12,510
+55
| +0.4% | +$6.5K | 0.95% | 46 |
|
|
2021
Q3 | $1.34M | Sell |
12,455
-10
| -0.1% | -$1.14K | 0.84% | 48 |
|
|
2021
Q2 | $1.4M | Buy |
12,465
+130
| +1% | +$14.6K | 0.87% | 46 |
|
|
2021
Q1 | $1.33M | Buy |
12,335
+100
| +0.8% | +$10.7K | 0.85% | 45 |
|
|
2020
Q4 | $1.31M | Hold |
12,235
| – | – | 0.91% | 43 |
|
|
2020
Q3 | $1.07M | Sell |
12,235
-300
| -2% | -$28.2K | 0.88% | 43 |
|
|
2020
Q2 | $1.23M | Buy |
+12,535
| New | +$1.1M | 1.05% | 43 |
|
|
2015
Q1 | – | Sell |
-29,726
| Closed | -$1.95M | – | 66 |
|
|
2014
Q4 | $1.95M | Sell |
29,726
-430
| -1% | -$27.1K | 1.25% | 38 |
|
|
2014
Q3 | $1.74M | Sell |
30,156
-5,830
| -16% | -$324K | 1.13% | 44 |
|
|
2014
Q2 | $2.03M | Hold |
35,986
| – | – | 1.31% | 41 |
|
|
2014
Q1 | $1.85M | Sell |
35,986
-520
| -1% | -$26.3K | 1.26% | 42 |
|
|
2013
Q4 | $1.93M | Buy |
36,506
+290
| +0.8% | +$14.3K | 1.35% | 38 |
|
|
2013
Q3 | $1.62M | Buy |
36,216
+180
| +0.5% | +$7.98K | 1.2% | 42 |
|
|
2013
Q2 | $1.49M | Buy |
+36,036
| New | +$1.58M | 1.16% | 42 |
|
Other funds holding ABBV
ECSS
ATO
Delta Capital Management's ABBV Position: Q2 2026 in Review
Delta Capital Management increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $51.6K and bringing the position to 17,205 shares worth $4.33M. The position accounts for 1.99% of the portfolio, ranked #7.
Delta Capital Management first reported a position in ABBV in Q2 2013 and has held it in 32 quarters since. The position peaked at $4.39M in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Delta Capital Management held 17,205 shares of AbbVie worth $4.33M as of Q2 2026.
- Delta Capital Management bought 240 AbbVie shares in Q2 2026, an estimated $51.6K.
- AbbVie made up 1.99% of Delta Capital Management's portfolio in Q2 2026, its #7 holding.
- Delta Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 32 quarters since.
- Delta Capital Management's AbbVie position peaked at $4.39M in Q3 2025.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Delta Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.